About ELUTIA INC.
Elutia is a medical technology company pioneering next-generation drug-eluting biomaterials to improve patient outcomes through innovative solutions in soft tissue repair and reconstruction. Their proprietary platform integrates drugs, biologics, and advanced science to address post-surgical complications.
Proprietary drug-eluting biomaterial platformHigh-performance allograft for soft tissue reconstruction (SimpliDerm)Engineered extracellular matrices for complex surgical repair (ProxiCor PC, ProxiCor CTR, VasCure VR)Integration of drugs, biologics, and advanced science in medical implants
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ELUTIA INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.